Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.91
+0.79 (5.59%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $28 | Buy | Maintains | $28 | +87.79% | Oct 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Upgrades $36 | Buy | Upgrades | $36 | +141.45% | Oct 6, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $28 | Buy | Maintains | $28 | +87.79% | Oct 5, 2026 |
| Wedbush | Wedbush | Buy Maintains $27 | Buy | Maintains | $27 | +81.09% | Sep 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $35 | Buy | Maintains | $35 | +134.74% | Jun 23, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $35 | Buy | Maintains | $35 | +134.74% | Apr 30, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 30, 2026 |